At the same time, there was a significant association between tumor budding and MET status, but in contrast to HER-2 and MSI, gastric cancer with a high budding grade tended to be MET-positive more frequently than tumors with a low budding grade. This evidence concerns the gene ERBB2 and neoplasm.